| Formulary Chapter 1: Gastro-intestinal system - Full Section
|
Notes:
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
01.01 |
Dyspepsia and gastro-oesophageal reflux disease (0,0)
|
|
|
Dyspepsia (0,0)
|
|
|
Gastro-oesophageal reflux disease (0,0)
|
|
01.01.01 |
Antacids and simeticone (0,0)
|
|
|
Aluminium and magnesium containing antacids
(1,5)
|
|
|
Aluminium-magnesium complexes
(0,1)
|
|
|
Antacid preparations containing simeticone
(0,3)
|
|
|
Simeticine alone
(0,2)
|
|
|
Antacid preparations containing dimeticone or local anaesthetics (0,0)
|
|
01.01.02 |
Compound alginates and proprietary indigestion preparations (0,0)
|
|
|
Compound alginate preparations
(2,7)
|
|
01.02 |
Antispasmodics and other drugs altering gut motility
(1,0)
|
|
|
Antimuscarinics
(1,4)
|
|
|
Other antispasmodics
(1,8)
|
|
|
Motility stimulants (0,0)
|
|
01.03 |
Antisecretory drugs and mucosal protectants (0,0)
|
|
|
Helicobacter pylori infection
(0,4)
|
|
|
NSAID-associated ulcers (0,0)
|
|
01.03.01 |
H2-receptor antagonists
(1,8)
|
|
01.03.02 |
Selective antimuscarinics (0,0)
|
|
01.03.03 |
Chelates and complexes
(2,1)
|
|
01.03.04 |
Prostaglandin analogues
(1,0)
|
|
01.03.05 |
Proton pump inhibitors (PPIs)
(8,6)
|
|
01.03.06 |
Other ulcer-healing drugs (0,0)
|
|
01.04 |
Acute diarrhoea (0,0)
|
|
01.04.01 |
Adsorbents and bulk-forming drugs
(1,1)
|
|
01.04.02 |
Antimotility drugs
(2,5)
|
|
01.04.03 |
Enkephalinase Inhibitors
(0,1)
|
|
01.05 |
Chronic bowel disorders (0,0)
|
|
|
Irritable bowel syndrome (0,0)
|
|
|
Malabsorption syndromes (0,0)
|
|
|
Inflammatory bowel disease (0,0)
|
|
|
Antibiotic-associated colitis (0,0)
|
|
|
Diverticular disease (0,0)
|
|
|
Aminosalicylates
(0,3)
|
|
|
Corticosteroids (0,0)
|
|
|
Food allergy (0,0)
|
|
|
Cytokine inhibitors (0,0)
|
|
|
Food Allergy
(0,1)
|
|
01.05.01 |
Aminosalicylates
(4,4)
|
|
01.05.02 |
Corticosteroids
(5,3)
|
|
|
Oral (0,0)
|
|
|
Topical (0,0)
|
|
|
Parenteral (0,0)
|
|
01.05.03 |
Drugs affecting the immune response
(4,0)
|
|
|
Cytokine inhibitors
(3,0)
|
|
|
Vedolizumab (0,0)
|
|
01.05.04 |
Food allergy (0,0)
|
|
01.06 |
Laxatives (0,0)
|
|
01.06.01 |
Bulk-forming laxatives
(1,7)
|
|
01.06.02 |
Stimulant laxatives
(6,7)
|
|
|
Other Stimulant laxatives (0,0)
|
|
01.06.03 |
Faecal softeners
(0,2)
|
|
01.06.04 |
Osmotic laxatives
(5,8)
|
|
01.06.05 |
Bowel cleansing preparations
(3,5)
|
|
01.06.06 |
Peripheral opiod-receptor antagonist
(1,3)
|
|
01.06.07 |
Other drugs used in constipation
(2,1)
|
|
01.06.08 |
Other preparations for bowel obstruction (0,0)
|
|
01.07 |
Local preparations for anal and rectal disorders (0,0)
|
|
01.07.01 |
Soothing haemorrhoidal preparations
(2,1)
|
|
01.07.02 |
Compound haemorrhoidal preparations with corticosteroids
(2,8)
|
|
01.07.03 |
Rectal sclerosants
(0,1)
|
|
01.07.04 |
Management of anal fissures
(2,0)
|
|
01.08 |
Stoma care
(0,1)
|
|
01.09 |
Drugs affecting intestinal secretions (0,0)
|
|
01.09.01 |
Drugs affecting biliary composition and flow
(2,4)
|
|
|
Other prepatations for biliary disorders
(0,1)
|
|
01.09.02 |
Bile acid sequestrants
(1,0)
|
|
01.09.03 |
Aprotinin (0,0)
|
|
01.09.04 |
Pancreatin
(3,6)
|
